Market Tracker

09/20 5:16pm ET

BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

5.27
Delayed Data
As of 4:00pm ET
 -0.16 / -2.95%
Today’s Change
3.75
Today|||52-Week Range
9.25
-16.75%
Year-to-Date
No recent news for BioCryst Pharmaceuticals Inc.

Today’s Trading

Previous close5.43
Today’s open5.43
Day’s range5.24 - 5.43
Volume1,873,620
Average volume (3 months)1,708,167
Market cap$436.9M
Dividend yield--
Data as of 4:00pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)-27.12%
Earnings growth (this year)+0.67%
Earnings growth (next 5 years)+24.73%
Revenue growth (last year)-45.39%
P/E ratioNM
Price/Sales17.70
Price/Book253.86

Competitors

 Today’s
change
Today’s
% change
CYADCelyad SA+0.30+0.56%
NSTGNanoString Technolog...-0.37-2.30%
MRSNMersana Therapeutics...+1.44+9.39%
SELBSelecta Biosciences ...+1.42+7.63%
Data as of 4:00pm ET, 09/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$26.4M
Annual profit (last year)-$55.1M
Net profit margin-209.25%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jon P. Stonehouse
Vice President-Investor Relations &
Operations
Robert Bennett
Corporate headquarters
Durham, North Carolina

Forecasts